Published online Mar 15, 2022. doi: 10.4251/wjgo.v14.i3.734
Peer-review started: May 17, 2021
First decision: July 4, 2021
Revised: July 16, 2021
Accepted: February 22, 2022
Article in press: February 22, 2022
Published online: March 15, 2022
Processing time: 296 Days and 23.8 Hours
Intestinal colonisation of Blastocystis hominis (Blastocystis) as a risk factor to the worsening of colorectal cancer (CRC).
There has been an increase in the prevalence of Blastocystis in CRC patients. Besides, various in vitro and in vivo studies have highlighted Blastocystis as an important risk factor for the worsening of CRC.
To perform a systematic review on all evidence on the association between CRC and Blastocystis.
A systematic review of the literature was performed by searching PubMed, Science Direct, Scopus and Google scholar databases up to February 2020.
Out of 12 studies selected for this systematic review, seven studies have confirmed the prevalence of Blastocystis. A total of four studies employing in vitro human colorectal carcinoma cell line study models showed significant cytopathic and immunological effects of Blastocystis. One in vivo experimental animal model study showed that there was a significant effect of infection with Blastocystis on exacerbation of colorectal carcinogenesis.
Blastocystis is a commonly identified microorganisms in CRC patients. These studies have provided supportive data that Blastocystis could exacerbate existing CRC via alteration in host immune response and increased oxidative damage.
Future studies of CRC and Blastocystis should attempt to determine the various stages of CRC that are most likely to be associated with Blastocystis and its association with other intestinal diseases.